Home

WILLIAM J OSHEA

CIK 1251725 · Vice Chairman · last filed 2019-05-13

WILLIAM J OSHEA is a Vice Chairman who has filed 45 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for TRVI, was dated May 13, 2019. Across all open-market trades the lifetime net is −$9.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions. 21 SEC filings were submitted jointly with SEPRACOR INC /DE/.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.82M

Companies

6

Total Filings

45

Lifetime Open-Market Net

-$9.54M

Filer Profile

Related Filers
SEPRACOR INC /DE/ — 21 joint filings, latest 2007-10-31
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRVI 10%+ Owner 114,080 $15.91 $1.82M $0 1 2019-05-13
OCUL Director — $10.62 — $0 4 2018-06-15
MAPP Director — $28.11 — $0 2 2013-03-04
EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted Director — — — $0 3 2010-01-20
PENWEST PHARMACEUTICALS CO (PPCO) Delisted Director 40,483 — — $0 15 2009-01-05
SEPRACOR INC /DE/ (SEPR) Delisted Vice Chairman 78,687 — — -$9.54M 16 2007-10-31

Recent Filings

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-05-13 TRVI Conv (C) +99,046 $0 EDGAR
2018-06-15 OCUL Grant (A) — $0 EDGAR
2017-06-01 OCUL Grant (A) — $0 EDGAR
2016-06-03 OCUL Grant (A) — $0 EDGAR
2015-11-09 OCUL Grant (A) — $0 EDGAR
2013-06-10 — Grant (A) — $0
2013-03-04 MAPP Disp (D) — $0 EDGAR
2012-05-25 — Grant (A) — $0
2012-01-17 MAPP Grant (A) — $0 EDGAR
2011-05-26 — Grant (A) — $0
Showing 1–10 of 45
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.